282 related articles for article (PubMed ID: 24037918)
1. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.
Pinsky PF; Church TR; Izmirlian G; Kramer BS
Cancer; 2013 Nov; 119(22):3976-83. PubMed ID: 24037918
[TBL] [Abstract][Full Text] [Related]
2. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
4. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.
Bonney A; Malouf R; Marchal C; Manners D; Fong KM; Marshall HM; Irving LB; Manser R
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013829. PubMed ID: 35921047
[TBL] [Abstract][Full Text] [Related]
5. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Incidentalomas in Association With Low-Dose Computed Tomography in the National Lung Screening Trial.
Loomans-Kropp HA; Dunn BK; Kramer BS; Pinsky P
Am J Epidemiol; 2020 Jan; 189(1):27-33. PubMed ID: 31595954
[TBL] [Abstract][Full Text] [Related]
7. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
8. Overdiagnosis in low-dose computed tomography screening for lung cancer.
Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
[TBL] [Abstract][Full Text] [Related]
9. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
10. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Cramer JD; Grauer J; Sukari A; Nagasaka M
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1071-1078. PubMed ID: 34709369
[TBL] [Abstract][Full Text] [Related]
12. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
14. Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.
Pastorino U; Boffi R; Marchianò A; Sestini S; Munarini E; Calareso G; Boeri M; Pelosi G; Sozzi G; Silva M; Sverzellati N; Galeone C; La Vecchia C; Ghirardi A; Corrao G
J Thorac Oncol; 2016 May; 11(5):693-699. PubMed ID: 26921675
[TBL] [Abstract][Full Text] [Related]
15. Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.
Doria-Rose VP; White MC; Klabunde CN; Nadel MR; Richards TB; McNeel TS; Rodriguez JL; Marcus PM
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1049-59. PubMed ID: 22573798
[TBL] [Abstract][Full Text] [Related]
16. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
Aberle DR; Abtin F; Brown K
J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434
[TBL] [Abstract][Full Text] [Related]
18. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
Pinsky P; Gierada DS
Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
[TBL] [Abstract][Full Text] [Related]
19. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
[TBL] [Abstract][Full Text] [Related]
20. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
